Arrowhead Research | ARWR - Marktkapitalisierung

Aktienkurs
65.14
Täglich Wechseln
-1.09 -1.65%
Monatlich
12.12%
Jährlich
452.50%
Q2 Prognose
63.36




Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Merck USD 261.26B 51.62B 2025-12
Nektar Therapeutics USD 14.34B 13.48B 2026-04
Novartis USD 292.21B 26.55B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
TG Therapeutics USD 4.73B 1B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12
Xencor USD 1.09B 256M 2025-12